Outset Medical (OM) Capital Expenditures Growth (1y) (2020 - 2026)
Outset Medical (OM) Capital Expenditures Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.80 Bn | 176.50 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 128.84 Bn | 125.96 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 108.59 Bn | 99.37 Bn | 6.41 Bn | 6.32% |
| 4 | Boston Scientific | 68.51 Bn | 67.06 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 48.18 Bn | 44.51 Bn | 1.29 Bn | 15.89% |
| 6 | Dexcom | 28.40 Bn | 27.28 Bn | 750.30 Mn | -11.95% |
| 7 | GE HealthCare Technologies | 28.16 Bn | 25.88 Bn | 1.98 Bn | 106.98% |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 24.66 Bn | 21.54 Bn | 2.07 Bn | -47.73% |
| 10 | Outset Medical | 81,206.82 | -286.56 Mn | 12.10 Mn | -47.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -47.15% |
| Dec 31, 2025 | 126.61% |
| Sep 30, 2025 | 20.00% |
| Jun 30, 2025 | -105.03% |
| Mar 31, 2025 | 232.43% |
| Dec 31, 2024 | 62.39% |
| Sep 30, 2024 | -49.49% |
| Jun 30, 2024 | -45.03% |
| Mar 31, 2024 | -95.43% |
| Dec 31, 2023 | -472.75% |
| Sep 30, 2023 | 126.79% |
| Jun 30, 2023 | -60.19% |
| Mar 31, 2023 | -45.20% |
| Dec 31, 2022 | -145.71% |
| Sep 30, 2022 | -234.83% |
| Jun 30, 2022 | 341.48% |
| Mar 31, 2022 | 60.83% |
| Dec 31, 2021 | 113.90% |
| Sep 30, 2021 | 48.39% |
| Jun 30, 2021 | -137.80% |